Clinical Trial Update: Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rituximab in patients with steroid-refractory chronic graft-versus-host disease. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-refractory Chronic Gvhd

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: The Korean Society of Hematopoietic Stem Cell Transplantation | Conditions: Steroid-Refractory Chronic GVHD | Phase 2 | Status: UNKNOWN